Drug · DIN 02470470
BENLYSTA
SINGLE-DOSE PREFILLED SYRINGE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 13, 2020.
- Drug Identification Number (DIN)
- 02470470
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Belimumab L04AG04
- Class
- Human
- Record last updated
- August 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BELIMUMAB | 200 MG | 1 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 7, 2017: NOC 20127Supplement to a New Drug Submission (SNDS) · New formulation and route of administration
Other DINs named BENLYSTA
- DIN 02370050 · Marketed
- DIN 02370069 · Marketed
- DIN 02470489 · Marketed